HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
Article in Frontiers in Immunology (June 2017)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (June 2017)
Article in Future Oncology (May 2017)